HIGHLIGHTS
- who: Xiaoyu Zhang from the University of Basel, Switzerland have published the research: Comparison of hematopoietic stem cell transplantation and immunosuppressive therapy as the first-line treatment option for patients with severe hepatitis-associated aplastic anemia, in the Journal: (JOURNAL)
- how: The authors conducted subgroup analysis to exclude confounding effects for example treatment types age of recipients history of infection and the ATG types.
SUMMARY
HAAA demonstrated poor prognosis attributable to more severe dysregulation of T_cell immunity than non-HA aplastic anemia. In the past decade, HID-HSCT are increasingly performed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.